Senisca (private company)

See something wrong or missing? Let us know
Offices:Exeter
Business model:B2B

Senisca is a British biotech startup which develops a new generation of oligonucleotide-based interventions - RNA senotherapeutics that target the process of cellular ageing

Investors: we tracked 7 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 8.89M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Senisca

Name Criteria
Denmark Octarine Bio
70%
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Austria Sarcura
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Spain Integra Tx
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Sixfold Bioscience
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Netherlands InnoSIGN
70%
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom MicrofluidX
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Switzerland Mybacs
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Denmark Biograil
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Spain ViveBiotech
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France PEP-Therapy
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top